Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy (Q73685231)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 1997

Language	Label	Description	Also known as
English	Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy	scientific article published on 01 September 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

colorectal cancer

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

F Lévi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Zidani

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J L Misset

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 September 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

350

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

9079

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

681-686

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronotherapy for gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing the natural history of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903358-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(97)03358-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291901%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73685231&oldid=2220636896"